This Informatica Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday
Benzinga · 05/28 12:04
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jefferies analyst Andrew Tsai downgraded the rating for Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) from Buy to Hold and lowered the price target from $29 to $2.5. Rocket Pharmaceuticals shares closed at $2.33 on Tuesday. See how other analysts view this stock.
- Wolfe Research analyst Alex Zukin downgraded the rating for Informatica Inc. (NYSE:INFA) from Outperform to Peer Perform. Informatica shares closed at $23.92 on Tuesday. See how other analysts view this stock.
- Wells Fargo analyst Finian O’Shea downgraded Runway Growth Finance Corp. (NASDAQ:RWAY) from Overweight to Equal-Weight and lowered the price target from $10 to $9.5. Runway Growth Finance shares closed at $9.83 on Tuesday. See how other analysts view this stock.
Considering buying INFA stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2025 Webull. All Rights Reserved